isomaltohexose has been researched along with Cardiometabolic Syndrome in 1 studies
*Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishnoi, M; Khanna, S; Kondepudi, KK; Shukla, G | 1 |
1 other study(ies) available for isomaltohexose and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Synbiotic (Lactiplantibacillus pentosus GSSK2 and isomalto-oligosaccharides) supplementation modulates pathophysiology and gut dysbiosis in experimental metabolic syndrome.
Topics: Animals; Dysbiosis; Gastrointestinal Microbiome; Lactobacillus; Male; Metabolic Syndrome; Oligosaccharides; Prebiotics; Probiotics; Rats, Sprague-Dawley | 2021 |